Search results
Results from the WOW.Com Content Network
Any value less than one is given a value of 1 (i.e. if bilirubin is 0.8 a value of 1.0 is used) to prevent subtraction from any of the three factors, since the natural logarithm of a positive number below 1 (greater than 0 and less than 1) yields a negative value. The etiology of liver disease was subsequently removed from the model because it ...
In less than 5% of cases, likely false positives or false negatives are highlighted. FibroTest has been validated for chronic hepatitis C , [ 10 ] chronic hepatitis B , [ 5 ] chronic hepatitis C or B with HIV co-infection, [ 11 ] alcoholic liver diseases (steatosis and steatohepatitis), [ 2 ] and non-alcoholic steatohepatitis (diabetes ...
The false positive rate (FPR) is the proportion of all negatives that still yield positive test outcomes, i.e., the conditional probability of a positive test result given an event that was not present. The false positive rate is equal to the significance level. The specificity of the test is equal to 1 minus the false positive rate.
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
In the diagram above, this positive post-test probability, that is, the posttest probability of a target condition given a positive test result, is calculated as: Positive posttest probability = True positives / (True positives + False positives) Similarly: The post-test probability of disease given a negative result is calculated as:
or "the probability of a person who has the disease testing positive divided by the probability of a person who does not have the disease testing positive." Here " T +" or " T −" denote that the result of the test is positive or negative, respectively.
Liver diseases, including conditions such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease (ALD), and viral hepatitis, are significant public health concerns worldwide. In the United States, NAFLD is the most common chronic liver condition, affecting approximately 24% of the population, with the prevalence rising due ...
All plasma proteins except Gamma-globulins are synthesised in the liver. [1] Human serum albumin, osmolyte and carrier protein; α-fetoprotein, the fetal counterpart of serum albumin; Soluble plasma fibronectin, forming a blood clot that stops bleeding; C-reactive protein, opsonin on microbes, [2] acute phase protein; Various other globulins